Endocrine-disrupting chemical (EDC) are defined by the Endocrine Society and the World Health Organization (WHO) as “an exogenous substance or mixture that alters function(s) of the endocrine system and consequently causes adverse health effects in an intact organism, or its progeny, or (sub)populations" [1; 2]. The structural similarities between EDCs and endogenous hormones lead to EDCs being able to interfere with the regular function of hormone receptors [3].ECDs are able to act at any stages of human causing several devastating effects on health of individuals, such as obesity, cancer, reproductive malformation and/or improper function, etc, [4; 5; 6; 7] eventually leading to death, dependent of type of EDC, dose, period, and time of EDC exposure or if have an EDC mix exposure [1; 2]. This research topic reported on techniques to study reproductive and metabolic disorders, such as use of magnetic resonance imaging (MRI) to study polycystic ovary syndrome (PCOS) [8].They demonstrated that cognitive impairment and emotional changes are associated with high serum testosterone levels, luteinizing hormone and fasting insulin levels in women with PCOS [8]. In vitro fertilization and embryo transfer (IVF-ET) was suggested to improve complications in spontaneous ovarian hyperstimulation syndrome caused by pituitary adenoma secreting folliclestimulating hormone [9] .In addition, this topic showed an important link between alterations of reproductive and metabolic health as result of EDC exposed, such as bisphenol A, bisphenol S, and bisphenol F, phthalate (2017 -2018). They suggest that cryptorchid boys are widely in utero exposed and with high blood bisphenol A levels and, to a lesser extent, also to its alternatives, such as bisphenol S and F. Hypospadias and decreased anogenital distance frequency were also associated with BP exposure [5].Other review study has shown that metabolic EDCs exposure (such as bisphenol A, phthalates, dichlorodiphenyldichloroethylene, dioxins, polychlorinated biphenyls, organochlorine pesticides, polybrominated flame retardants and perfluorinated compounds, etc) act as obesogenic chemical, leading to metabolic abnormalities, impairing normal adipose tissue function, increasing adipose tissue mass, remodeling, hypoxia, inflammation, etc with prevalence of non-monotonic doseresponse curves [1; 2; 4]. The abnormal metabolic adipose tissue function, as result of EDC exposure alters adipokines profile release and hormone actions [1; 2; 4]. While it is now well established that abnormal adipose tissue secretes adipocytokines that could help to promote tumor progression. In parallel, EDCs exposure has been implicated in the development of cancers, in particular hormone-dependent cancers (prostate, testis, breast, endometrium, thyroid) [4]. This research topic brings together 6 papers (4 original research and 2 review articles) on the endocrine and metabolic disorders, such as polycystic ovary syndrome (PCOS) and pituitary adenoma secreting follicle-stimulating hormone. In addition, the topic reported a complex toxicologic role of endocrine disruption chemical (EDC) exposure, such as bisphenol A (BPA), bisphenol S (BPS), and bisphenol F (BPF), phthalate metabolites, mercury, etc, linked with human health complications, such as cancer, obesity, reproductive abnormalities, etc.Understanding the interplay between some EDCs, as well as their exposure from different sources and physiologic abnormalities are highly relevant for human health in the world. Clearly, research in this field is advancing at a rapid pace. The articles in this Research Topic highlight novel findings and unanswered questions for future investigation.
5 Authors
- YZ
Yuqing Zhang
Department of Women Health Care, Women’s Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital, China
- YL
Yingying Lu
Department of Obstetrics and Gynecology, Women’s Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital, China
- HM
Huiyuan Ma
Department of Obstetrics and Gynecology, Women’s Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital, China
- QX
Qing Xu
Department of Obstetrics and Gynecology, Women’s Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital, China
- XW
Xiaoli Wu
Department of Women Health Care, Women’s Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital, China


